FURLAN, ROBERTO
 Distribuzione geografica
Continente #
AS - Asia 1.165
EU - Europa 1.072
NA - Nord America 1.022
SA - Sud America 70
AF - Africa 8
Totale 3.337
Nazione #
US - Stati Uniti d'America 1.010
CN - Cina 518
SE - Svezia 423
HK - Hong Kong 315
SG - Singapore 282
RU - Federazione Russa 204
IT - Italia 177
DE - Germania 84
BR - Brasile 64
FI - Finlandia 46
AT - Austria 40
IE - Irlanda 35
GB - Regno Unito 31
NL - Olanda 17
IN - India 11
FR - Francia 8
JP - Giappone 8
CA - Canada 6
IR - Iran 5
MX - Messico 5
SA - Arabia Saudita 5
TR - Turchia 5
KR - Corea 4
EG - Egitto 3
PK - Pakistan 3
CL - Cile 2
CY - Cipro 2
DZ - Algeria 2
PL - Polonia 2
UA - Ucraina 2
AR - Argentina 1
BE - Belgio 1
BO - Bolivia 1
CO - Colombia 1
ES - Italia 1
GR - Grecia 1
ID - Indonesia 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
MA - Marocco 1
NI - Nicaragua 1
PY - Paraguay 1
SN - Senegal 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 3.337
Città #
Shanghai 341
Hong Kong 313
Singapore 179
Lawrence 174
Princeton 172
Ashburn 171
Milan 79
Moscow 78
New York 53
Nuremberg 42
Boardman 41
Helsinki 41
Washington 40
Dublin 35
Dallas 27
Los Angeles 19
Vienna 17
Guangzhou 16
Rome 16
Seattle 16
Manchester 11
Beijing 9
Xi'an 8
London 7
Pune 7
Reston 7
Shenzhen 7
Amsterdam 6
Austin 5
Cesano Boscone 5
Florence 5
Jeddah 5
Kunming 5
Lappeenranta 5
São Paulo 5
Borås 4
Edgware 4
Hangzhou 4
Harrow 4
Manassas 4
Santa Clara 4
Chions 3
Gronau 3
Mexico City 3
Qina 3
Rio de Janeiro 3
Tomblaine 3
Toronto 3
Wuxi 3
Belo Horizonte 2
Bergamo 2
Canneto sull'Oglio 2
Central 2
Chandigarh 2
Changsha 2
Chaponnay 2
Chuo 2
Clifton 2
Foshan 2
Frankfurt am Main 2
Freiburg im Breisgau 2
Genoa 2
Jiaxing 2
Karachi 2
Mapo-gu 2
Marseille 2
Munich 2
Naples 2
Nicosia 2
Phoenix 2
Quanzhou 2
Salford 2
San Mateo 2
Shinjuku 2
São José dos Campos 2
Weifang 2
Wuhan 2
's-Hertogenbosch 1
Algiers 1
Andover 1
Arenzano 1
Asunción 1
Barbacena 1
Belleville 1
Berlin 1
Betim 1
Bishkek 1
Bragado 1
Brierley Hill 1
Brussels 1
Bursa 1
Caetanópolis 1
Calama 1
Campinas 1
Campo Grande 1
Canoas 1
Carate Brianza 1
Cassolnovo 1
Castel Maggiore 1
Catanduva 1
Totale 2.094
Nome #
Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up 43
Clinical Features and Biomarkers to Differentiate Primary and Amyotrophic Lateral Sclerosis in Patients With an Upper Motor Neuron Syndrome 42
Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors 42
A peripheral inflammatory signature discriminates bipolar from unipolar depression: A machine learning approach 40
Brain correlates of depression, post-traumatic distress, and inflammatory biomarkers in COVID-19 survivors: A multimodal magnetic resonance imaging study 40
Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study 39
Neurofilaments light: Possible biomarker of brain modifications in bipolar disorder 31
Neuroinflammation in Bipolar Depression 30
Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients 29
One-year mental health outcomes in a cohort of COVID-19 survivors 29
Higher baseline interleukin-1β and TNF-α hamper antidepressant response in major depressive disorder 28
Long-term consequences of COVID-19 on cognitive functioning up to 6 months after discharge: role of depression and impact on quality of life 28
COVID-19 has no impact on disease activity, progression and cognitive performance in people with multiple sclerosis: A 2-year study 27
Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica. 26
T regulatory cells are markers of disease activity in multiple sclerosis patients 25
CXCL10 levels at hospital admission predict COVID-19 outcome: hierarchical assessment of 53 putative inflammatory biomarkers in an observational study 25
INCREASE OF MYELOID MICROVESICLES IN THE CEREBROSPINAL FLUID AS BIOMARKER OF MICROGLIA/MACROPHAGE ACTIVATION IN NEUROLOGICAL DISORDERS 24
ALTERED MRNA LEVELS OF CHEMOKINES AND CYTOKINES IN SCHIZOPHRENIA AND BIPOLAR DISORDER 24
Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice 24
A gene therapy approach to treat demyelinating diseases using nonreplicative herpetic vectors engineered to produce cytokines 24
Neutrophil-to-lymphocyte ratio: a marker of neuro-inflammation in multiple sclerosis? 24
Spinal Fluid Myeloid Microvesicles Predict Disease Course in Multiple Sclerosis 24
Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis 23
Neuromyelitis optica spectrum disorder: the importance of NMO-IgG in clinical practice 23
Cytokine therapy in immune-mediated demyelinating diseases of the central nervous system: a novel gene therapy approach 23
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicantre study 23
MiR-125a-3p timely inhibits oligodendroglial maturation and is pathologically up-regulated in human multiple sclerosis 23
Integrated evaluation of a panel of neurochemical biomarkers to optimize diagnosis and prognosis in amyotrophic lateral sclerosis 23
Mood-congruent negative thinking styles and cognitive vulnerability in depressed COVID-19 survivors: A comparison with major depressive disorder 23
Lower levels of glutathione in the anterior cingulate cortex associate with depressive symptoms and white matter hyperintensities in COVID-19 survivors 23
Similar low frequency of anti-MOG IgG and IgM in MS patients and healthy subjects 22
Classical and unconventional pathways of vesicular release in microglia 22
Cytokines and immunity in multiple sclerosis: the dual signal hypothesis 22
Absence of oligoclonally restricted immunoglobulins in tears from multiple sclerosis patients 22
Neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis 22
Free Light Chains and Intrathecal B Cells Activity in Multiple Sclerosis: A Prospective Study and Meta-Analysis 22
Subclinical anterior optic pathway involvement in early multiple sclerosis and clinically isolated syndromes 22
Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients 21
B cell depletion attenuates CD27 signaling of T helper cells in multiple sclerosis 21
Ventilation With Argon Improves Survival With Good Neurological Recovery After Prolonged Untreated Cardiac Arrest in Pigs 21
A nitric oxide releasing derivative of flurbiprofen inhibits experimental autoimmune encephalomyelitis 21
Cytokine gene therapy of autoimmune demyelination revisited using herpes simplex virus type-1-derived vectors 21
Dysregulation of MS risk genes and pathways at distinct stages of disease 21
Transcriptional dysregulation of Interferome in experimental and human Multiple Sclerosis 21
AMBRA1 Controls Regulatory T-Cell Differentiation and Homeostasis Upstream of the FOXO3-FOXP3 Axis 21
CSF extracellular vesicles and risk of disease activity after a first demyelinating event 21
ACID SPHINGOMYELINASE TRIGGERS P2X7-INDUCED MICROPARTICLE RELEASE FROM GLIAL CELLS 20
Clinical significance of the number of oligoclonal bands in patients with clinically isolated syndromes. 20
Cerebrospinal fluid analysis in immunoglobulin G4-related hypertrophic pachymeningitis 20
Allogeneic haematopoietic stem cell transplantation in refractory neuromyelitis optica spectrum disorders 20
miR-21 sustains CD28 signalling and low-affinity T-cell responses at the expense of self-tolerance 20
Gene transfer to pancreatic islets mediated by a replication incompetent HSV-1 19
Inflammation affects striatal glutamate transmission since the pre-clinical phase of experimental autoimmune encephallonlyelitis 19
DIFFERENTIAL miRNAs EXPRESSION PROFILE BETWEEN TREG-VERSUS T EFFECTOR CELLS IN COURSE OF MULTIPLE SCLEROSIS 19
In vivo fate analysis reveals the multipotent and self-renewal features of embryonic AspM expressing cells 19
Cxcl10 enhances blood cells migration in the sub-ventricular zone of mice affected by experimental autoimmune encephalomyelitis 19
Natural Killer cells protect white matter integrity in Bipolar Disorder 19
Disease-modifying treatments modulate myeloid cells in multiple sclerosis patients 19
Synapsin I deletion reduces neuronal damage and ameliorates clinical progression of experimental autoimmune encephalomyelitis 19
Monocyte mitochondrial dysfunction, inflammaging, and inflammatory pyroptosis in major depression 19
Plasma neurofilament light chain levels and cognitive testing as predictors of fast progression in Alzheimer’s disease 19
Evaluation of different techniques to detect anti-aquaporin 4 antibodies 18
Classification of Psychoses Based on Immunological Features: A Machine Learning Study in a Large Cohort of First-Episode and Chronic Patients 18
Administration of an MCP-1 variant to EAE mice prevents inflammatory cell recruitment and protects from demyelination and axonal loss 18
Neural progenitor cells orchestrate microglia migration and positioning into the developing cortex 18
IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis 18
Vitamin D levels and risk of developing multiple sclerosis 18
Stiff-man syndrome and autoimmunity; pathogenetic problems 18
Absence of central nervous system pathology in severe combined immunodeficiency mice intraperitoneally injected with peripheral blood lymphocytes from multiple sclerosis patients 18
LONG-TERM DISEASE CONTROL OF REFRACTORY NEUROMYELITIS OPTICA AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION 18
Absence of an intrathecal immune reaction to a helper-dependent adenoviral vector delivered into the cerebrospinal fluid of non-human primates 18
Abnormal activity of the Na/Ca exchanger enhances glutamate transmission in experimental autoimmune encephalomyelitis 18
2D immunomic approach for the study of IgG autoantibodies in the experimental model of multiple sclerosis 18
Differential local tissue permissiveness influences the final fate of GPR17-expressing oligodendrocyte precursors in two distinct models of demyelination 17
Artificial intelligence techniques in the diagnosis of multiple sclerosis 17
Cytokine gene delivery into the central nervous system using intrathecally injected non-replicative viral vectors 17
Animal models of multiple sclerosis 17
Central Nervous system delivery of Interleukin 4 by a nonreplicative herpes simplex type 1 viral vector ameliorates autoimmune demyelination 17
Real time RT-PCR determination of mRNA levels of cytokine, chemokine and chemokine receptors in PBLs from MS patients: clinical and MRI correlations 17
Activated macrophages release microvesicles containing polarized M1 or M2 mRNAs 17
Platelet glutamate uptake and Th1 cells inversely correlate in relapsing/remitting and in progressive multiple sclerosis 17
Allogeneic Hematopoietic Stem Cell Transplantation For Severe Neuromyelitis Optica 17
Activation of invariant NKT cells by alpha GalCer administration protects mice from MOG35-55-induced EAE: critical roles for administration route and IFN-gamma 16
Administration of a monomeric CCL2 variant to EAE mice inhibits inflammatory cell recruitment and protects from demyelination and axonal loss 16
A helper dependent adenovirus efficiently delivers bioactive FGF-II to the CNS 15
Opposite changes of glutamate and GABA transmission in the striatum of mice with experimental autoimmune encephalomyelitis 15
Motor-evoked potentials (MEPs) for monitoring chronic cortico-spinal damage in MOG35-55-induced experimental autoimmune encephalomyelitis (EAE) 15
iAstrocytes do not restrain T cell proliferation in vitro 15
Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndrome 15
Lentiviral-mediated administration of IL-25 in the CNS induces alternative activation of microglia 15
Intrathecal delivery of IFN-gamma protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes 15
Oxidative stress is differentially present in multiple sclerosis courses, early evident, and unrelated to treatment. 15
Serum neurofilaments increase at progressive multifocal leukoencephalopathy onset in natalizumab-treated multiple sclerosis patients 15
MYD88 L265P mutation and interleukin-10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study 15
Diagnostic value of IgG4 Indices in IgG4-related hypertrophic pachymeningitis. 15
The therapeutic effect of mesenchymal stem cell transplantation in experimental autoimmune encephalomyelitis is mediated by peripheral and central mechanisms 14
Evaluation of different techniques to detect anti-acquaporin 4 antibodies in neuromyelitis optica patients 14
A model of HTLV-I infection in the SCID mouse 14
Adenovirus-mediated IL-4 transfer is protective in ischemia/reperfusion brain injury 14
Circulating cytotoxic immune cell composition, activation status and toxins expression associate with white matter microstructure in bipolar disorder 14
Totale 2.121
Categoria #
all - tutte 59.668
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.668


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207 0 0 0 0 0 0 0 0 0 6 0 1
2020/202118 0 0 0 3 0 0 5 0 8 0 2 0
2021/2022162 6 4 1 57 14 18 16 5 7 15 7 12
2022/20231.070 398 175 50 6 8 85 37 49 28 24 201 9
2023/2024784 7 44 108 61 103 174 20 62 8 26 34 137
2024/20251.608 376 68 54 94 130 313 499 74 0 0 0 0
Totale 3.708